Valve Disease

Valve disease in dogs encompasses a group of cardiac conditions affecting the heart valves, which are essential structures that ensure blood flows in the correct direction through the heart chambers and into the major blood vessels. The heart contains four valves: the mitral valve and tricuspid valve between the atria and ventricles, and the aortic valve and pulmonic valve between the ventricles and major arteries. When these valves malfunction due to degenerative changes, congenital malformations, or infection, the heart's efficiency is compromised, leading to a spectrum of clinical consequences. Valve disease represents the most common form of heart disease in dogs, affecting millions of dogs worldwide and accounting for approximately 75 percent of all canine cardiac cases seen in veterinary practice.

The most prevalent form of valve disease in dogs is degenerative valve disease, also known as myxomatous mitral valve disease or endocardiosis. This condition involves progressive degeneration of the valve leaflets, most commonly affecting the mitral valve on the left side of the heart. The valve tissue gradually thickens, becomes irregular, and loses its normal smooth texture, preventing the valve from closing properly. This results in regurgitation, where blood leaks backward through the valve with each heartbeat. While the mitral valve is most frequently affected, the tricuspid valve may also be involved, either alone or in combination with mitral valve disease. Congenital valve abnormalities such as subaortic stenosis and pulmonic stenosis represent another category of valve disease present from birth.

The impact of valve disease on a dog's health varies tremendously based on the type and severity of the valve dysfunction. Many dogs live for years with valve disease before developing any clinical symptoms, as the heart compensates by enlarging and working harder to maintain adequate circulation. However, this compensation has limits, and progressive valve dysfunction eventually overwhelms the heart's adaptive capacity. At this point, dogs develop congestive heart failure, characterized by fluid accumulation in the lungs, abdomen, or both. The resulting respiratory distress, exercise intolerance, and diminished quality of life significantly affect both the dog and their family. Understanding the progressive nature of valve disease helps owners appreciate the importance of monitoring and timely intervention.

Treatment of valve disease in dogs has advanced significantly in recent years, offering hope for improved outcomes and extended quality lives. Medical management using diuretics, cardiac medications, and ACE inhibitors can effectively control symptoms and slow disease progression in many dogs. Surgical repair of the mitral valve, once considered unfeasible in veterinary medicine, is now performed at specialized centers with success rates approaching those achieved in human medicine. Early detection through regular cardiac screening, particularly in predisposed breeds, allows for timely initiation of appropriate therapies. Working with a veterinarian or veterinary cardiologist to develop an individualized management plan provides the best opportunity for dogs with valve disease to maintain quality of life for as long as possible.

The primary causes of valve disease in dogs differ depending on whether the condition is degenerative, congenital, or acquired through infection. Degenerative valve disease, the most common form, results from age-related changes to the valve tissue. The extracellular matrix of the valve leaflets undergoes myxomatous degeneration, where the organized collagen and elastin fibers that provide valve structure break down and are replaced by loose, disorganized connective tissue. This process causes the valve leaflets to become thickened, irregular, and floppy, preventing them from creating a tight seal when closed. The degenerative process typically begins in middle age and progresses over time, eventually causing significant valve dysfunction in affected dogs.

Genetic and hereditary factors play a substantial role in degenerative valve disease, explaining the strong breed predispositions observed clinically. Small breed dogs are dramatically overrepresented among dogs with myxomatous mitral valve disease, and within small breeds, certain breeds such as Cavalier King Charles Spaniels have exceptionally high prevalence. Research in Cavalier King Charles Spaniels has identified specific genetic loci associated with early-onset valve disease, and family studies demonstrate clear heritability patterns. The exact genes responsible remain under investigation, but the polygenic inheritance pattern is well established. Congenital valve diseases such as subaortic stenosis also show breed predisposition and familial inheritance, indicating genetic causes for these malformations.

Environmental and lifestyle factors have minimal direct impact on the development of valve disease, unlike some other cardiac conditions. The degenerative process appears to be primarily driven by genetics and age rather than diet, exercise, or environmental exposures. However, factors that increase cardiac workload may accelerate the consequences of existing valve disease. Obesity places additional strain on the heart and may hasten the progression from compensated valve disease to heart failure. Dental disease has been investigated as a potential contributor through bacteremia and inflammation, though direct causation remains debated. Maintaining overall health through appropriate nutrition and weight management supports cardiovascular function but cannot prevent genetically predetermined valve degeneration.

Risk factors for developing valve disease center on breed, age, and size. Small breed dogs face significantly higher risk for degenerative mitral valve disease than large breeds, with prevalence exceeding 75 percent in small breeds over 16 years of age. Age is the strongest risk factor, with disease prevalence increasing progressively in older dogs. Male dogs appear to develop clinical signs and progress to heart failure earlier than females with similar valve pathology. Cavalier King Charles Spaniels represent an exception to the typical age pattern, often developing significant valve disease by 5 years of age. Large and giant breeds face increased risk for certain congenital valve defects, with subaortic stenosis common in Golden Retrievers, German Shepherds, and Newfoundlands.

The mechanism by which valve disease leads to heart dysfunction involves volume overload and progressive cardiac remodeling. When a valve fails to close properly, blood regurgitates backward with each heartbeat rather than moving forward efficiently. This regurgitant volume adds to the normal blood volume the heart must pump, increasing the total workload. The heart responds by enlarging the affected chambers to accommodate the increased volume, a process called eccentric hypertrophy. While this compensatory enlargement maintains forward blood flow initially, it stretches the valve apparatus further, worsening regurgitation and creating a progressive cycle. Eventually, the heart can no longer compensate adequately, and elevated pressures cause fluid to leak from blood vessels into the lungs, abdomen, or peripheral tissues, manifesting as congestive heart failure.

Early warning signs of valve disease in dogs are often subtle or entirely absent, which is why the condition frequently goes undetected until a heart murmur is discovered during routine veterinary examination. A heart murmur is an abnormal whooshing or swishing sound heard through a stethoscope, caused by turbulent blood flow through the diseased valve. Many dogs with early valve disease have no symptoms at all, and the murmur is found incidentally during vaccination appointments or other wellness visits. When early symptoms do occur, they may be so mild that owners attribute them to normal aging: slightly reduced enthusiasm for long walks, taking slightly longer to recover after exercise, or preferring shorter play sessions. These subtle changes often precede overt symptoms by months or years.

Common symptoms of valve disease become apparent as the condition progresses and the heart's compensatory abilities begin to fail. A persistent cough is one of the most frequently reported symptoms, often occurring at night or when the dog first lies down to rest. This cough results from an enlarged heart pressing on the airways or from fluid beginning to accumulate in the lungs. Exercise intolerance manifests as tiring easily during walks, reluctance to climb stairs, or decreased interest in play activities. Some dogs show increased respiratory rate and effort even at rest. Appetite may decrease, and weight loss can occur despite adequate food availability. These symptoms typically develop gradually, making their onset difficult to pinpoint precisely.

Behavioral changes associated with valve disease reflect the dog's compromised cardiovascular status and reduced oxygen delivery to tissues. Dogs may become less active overall, spending more time resting and showing decreased interest in activities they previously enjoyed. Sleep patterns may change, with dogs seeming restless at night due to coughing or difficulty breathing when lying flat. Some dogs prefer to sleep with their head elevated or even sitting up to ease breathing. Anxiety and restlessness may increase, particularly during episodes of respiratory distress. Social behavior may shift, with some dogs becoming clingy while others withdraw and seek quiet, isolated spots.

Physical signs that owners may observe in dogs with progressive valve disease include visible changes in breathing pattern, such as increased belly movement with each breath or flared nostrils indicating respiratory effort. In right-sided heart failure, the abdomen may become distended with fluid, giving the dog a pot-bellied appearance. The gums may appear paler than normal or slightly bluish in severe cases indicating poor oxygenation. Some dogs develop fainting episodes, particularly during excitement or exertion, caused by cardiac arrhythmias or inadequate cardiac output. Weight loss despite normal or reduced appetite often accompanies advanced disease.

Symptom progression in valve disease typically follows a predictable pattern, though the timeline varies among individual dogs. The preclinical phase, where a murmur is present but no symptoms exist, may last years. Gradual transition to clinical disease brings coughing, exercise intolerance, and increased respiratory rate. As heart failure develops, symptoms intensify and may include severe respiratory distress and marked activity reduction. Episodes of acute decompensation may punctuate the chronic progressive decline, requiring urgent veterinary intervention. Some dogs experience relatively stable plateaus between periods of worsening, while others decline more steadily.

Emergency symptoms requiring immediate veterinary attention include severe respiratory distress with open-mouth breathing, blue or gray gum color, collapse or loss of consciousness, and extreme weakness with inability to stand. Rapidly accumulating abdominal fluid causing severe distension represents urgent heart failure requiring drainage. Any sudden worsening of breathing, particularly with anxious behavior and refusal to lie down, indicates critical pulmonary edema requiring emergency treatment. Dogs with known valve disease should be monitored closely, and owners should have a plan for accessing emergency veterinary care when needed, as prompt treatment of acute decompensation can be life-saving.

The initial examination for valve disease typically begins with the detection of a heart murmur during routine physical examination. The veterinarian listens to the heart with a stethoscope, assessing for abnormal sounds that indicate turbulent blood flow. The murmur is characterized by its intensity, timing within the cardiac cycle, and location on the chest wall where it is heard loudest. In mitral valve disease, the murmur is typically loudest on the left side of the chest, while tricuspid valve murmurs are heard best on the right. The veterinarian also evaluates heart rate and rhythm, lung sounds, pulse quality, and signs of fluid retention. A thorough history explores any symptoms the owner has noticed, including exercise tolerance, breathing patterns, coughing, and appetite.

Diagnostic tests for valve disease provide detailed information about cardiac structure, function, and the severity of valve dysfunction. Thoracic radiographs reveal heart size and shape, with characteristic enlargement patterns indicating which chambers are affected. The radiographs also show lung changes associated with heart failure, such as pulmonary edema or pleural effusion. An electrocardiogram records the heart's electrical activity and may reveal enlargement patterns or rhythm disturbances. Blood tests including cardiac biomarkers such as NT-proBNP or cardiac troponin can help assess the severity of heart disease and distinguish cardiac from non-cardiac causes of similar symptoms.

Echocardiography is the gold standard diagnostic test for valve disease, providing definitive visualization of valve anatomy and function. This ultrasound examination shows the structure of the valve leaflets, allowing identification of thickening, irregularity, or prolapse characteristic of degenerative changes. Doppler imaging demonstrates the direction and velocity of blood flow, quantifying the degree of regurgitation. Measurements of chamber sizes document the extent of cardiac remodeling. Serial echocardiograms over time track disease progression and guide treatment decisions. The echocardiogram also identifies complications such as ruptured chordae tendineae or left atrial tear.

Differential diagnosis for valve disease includes other conditions that may cause similar murmurs or symptoms. Congenital defects such as patent ductus arteriosus or ventricular septal defects produce murmurs but have distinctive characteristics. Dilated cardiomyopathy causes heart enlargement and may produce secondary valve regurgitation but primarily affects the heart muscle rather than the valves. Infectious endocarditis involves bacterial infection of the valve tissue and requires specific antibiotic treatment. Heartworm disease affects the right side of the heart and can cause murmurs and heart failure. Non-cardiac causes of coughing, such as tracheal collapse or chronic bronchitis, must be distinguished from cardiac cough. The combination of physical examination findings, imaging results, and clinical history allows accurate diagnosis and appropriate treatment planning.

Emergency treatment for dogs presenting with acute decompensated heart failure from valve disease focuses on stabilizing respiratory distress and reducing fluid overload. Oxygen supplementation improves blood oxygen levels and reduces the work of breathing. Dogs may receive oxygen through various methods including nasal cannulas, face masks, oxygen cages, or even intubation in severe cases. Intravenous furosemide rapidly removes excess fluid through the kidneys, reducing pulmonary edema and pleural effusion. Sedation with medications such as butorphanol helps reduce anxiety and respiratory effort. In cases of severe pleural effusion, thoracocentesis removes fluid from around the lungs to allow lung expansion. Dogs in cardiogenic shock may require additional cardiovascular support.

Medical management of valve disease varies based on disease stage and follows evidence-based guidelines developed from extensive clinical research. In the preclinical stage with minimal or no cardiac enlargement, no medical treatment may be needed, though monitoring is essential. When significant cardiac enlargement develops but before symptoms appear, some veterinarians recommend starting pimobendan to delay onset of heart failure. Once symptoms develop, comprehensive medical therapy typically includes furosemide to control fluid retention, pimobendan to improve heart function, and ACE inhibitors such as enalapril or benazepril to reduce cardiac workload. Spironolactone adds additional diuretic effect while potentially reducing cardiac fibrosis. Additional medications may be added as disease progresses or complications develop.

Surgical options for valve disease have become increasingly available and successful at specialized veterinary cardiac surgery centers. Mitral valve repair involves reconstructing the valve structures to restore normal function, an approach that has shown excellent outcomes in human medicine and is now performed in dogs. The procedure typically involves annuloplasty to reduce the dilated valve ring, replacement of ruptured chordae tendineae, and modification of the valve leaflets as needed. Success rates at experienced centers exceed 90 percent, with many dogs achieving dramatic improvement in clinical status and long-term survival. The surgery requires cardiopulmonary bypass and specialized expertise, limiting its availability to major veterinary cardiac centers.

Supportive care for dogs with valve disease encompasses dietary management, activity guidelines, and overall health maintenance. Sodium restriction helps minimize fluid retention, though the degree of restriction varies with disease severity. Moderate, regular exercise is generally encouraged as tolerated, as some physical activity maintains muscle mass and quality of life. Maintaining appropriate body weight reduces cardiac workload. Dental care remains important to prevent bacteremia that could cause endocarditis on already compromised valves. Regular monitoring of resting respiratory rate at home helps detect early decompensation before crisis develops.

Alternative and complementary treatments may provide additional support for dogs with valve disease alongside conventional therapy. Omega-3 fatty acid supplementation has anti-inflammatory effects and may provide modest cardiovascular benefits. Antioxidant supplements including vitamin E and coenzyme Q10 may support cellular function. Traditional Chinese veterinary medicine and acupuncture are offered by some practitioners for cardiac patients. These complementary approaches should be discussed with the treating veterinarian and integrated appropriately with conventional medical management rather than used as substitutes for proven therapies.

Treatment decisions for valve disease consider multiple factors including disease stage, symptom severity, quality of life, owner preferences, and financial resources. Dogs with mild disease and no symptoms require monitoring but may not need active treatment. Progressive disease warrants medical management tailored to the individual patient. Surgical candidates are typically younger dogs with severe disease who are otherwise good surgical risks and whose owners can access specialized surgical centers. Goals of care should be discussed openly, with realistic expectations about disease progression and the palliative nature of most medical therapy. Quality of life should guide decisions throughout the disease course.

The recovery timeline for dogs with valve disease depends on the specific context: recovery from acute decompensated heart failure, adjustment to newly initiated medical therapy, or recovery from surgical intervention. Dogs hospitalized for acute heart failure typically show improvement within 24 to 72 hours with appropriate treatment, though achieving optimal stability may take longer. Coughing and respiratory distress improve as pulmonary edema resolves. Dogs started on medical therapy for newly symptomatic valve disease often show noticeable improvement in energy and breathing within days to weeks as medications take effect and fluid balance normalizes. Surgical valve repair requires longer recovery, typically two to three months for full healing, though dogs often show dramatic clinical improvement within weeks.

Post-treatment care requirements for dogs with medically managed valve disease include daily medication administration, dietary management, and ongoing monitoring. Medications must be given consistently, often multiple times daily, for the remainder of the dog's life. The specific protocol varies among patients and evolves as disease progresses. Dietary sodium restriction supports fluid management and may allow lower medication doses. Regular recheck appointments allow assessment of disease status, medication effectiveness, and dose adjustment. Home monitoring of resting respiratory rate provides early warning of decompensation. Owners should understand what symptoms warrant urgent veterinary contact.

Prognosis factors for valve disease include the severity of disease at diagnosis, the degree of cardiac remodeling, the presence of complications such as arrhythmias or ruptured chordae, and the response to therapy. Dogs diagnosed early in the disease course before significant cardiac enlargement have the best long-term outlook. Those that respond well to medical therapy and maintain stable clinical status may live comfortably for years. Factors predicting poorer outcomes include large left atrial size, presence of pulmonary hypertension, atrial fibrillation, and frequent decompensation episodes despite maximal therapy. Dogs that undergo successful surgical repair have dramatically improved prognosis compared to medical management alone.

The long-term outlook for dogs with valve disease has improved substantially with advances in medical and surgical treatment. Many dogs with well-managed valve disease maintain good quality of life for one to several years after diagnosis, depending on disease severity at presentation. The condition is progressive, and most medically managed dogs eventually develop refractory heart failure. However, the journey can include many months of comfortable, enjoyable life with appropriate management. Owners should maintain realistic expectations while celebrating the good times. Planning for end-of-life decisions before crisis situations allows for more thoughtful choices that prioritize the dog's comfort and dignity.

Primary prevention of degenerative valve disease is not currently possible because the condition is primarily determined by genetics and age. Unlike some diseases that can be prevented through vaccination, diet, or lifestyle modification, valve degeneration appears intrinsic to the biology of predisposed dogs. However, maintaining overall cardiovascular health through appropriate body weight, regular moderate exercise, and good general health care supports heart function and may help dogs with early valve changes maintain compensation longer. Avoiding obesity is particularly important, as excess weight places additional demands on an already compromised heart.

Breeding and genetic prevention represents the most promising avenue for reducing valve disease prevalence in future generations. Because degenerative valve disease has strong hereditary components, selecting breeding stock based on cardiac health status can reduce disease transmission. The Mitral Valve Disease Breeding Protocol developed for Cavalier King Charles Spaniels recommends breeding only dogs that are free of murmurs at specific ages, with progressively older parents being acceptable. Adherence to such protocols has the potential to delay disease onset and reduce severity in affected breeds. All breeds with elevated valve disease prevalence should incorporate cardiac screening into breeding programs.

Nutritional prevention strategies focus on supporting cardiovascular health rather than preventing valve degeneration directly. Maintaining appropriate body weight through balanced nutrition and portion control reduces cardiac workload throughout life. Diets with appropriate levels of taurine, L-carnitine, and other nutrients support heart muscle function. Omega-3 fatty acids from fish oil have mild anti-inflammatory effects that may support cardiovascular health. These nutritional considerations are part of overall health maintenance rather than specific valve disease prevention.

Health maintenance through regular veterinary care enables early detection of valve disease, which improves management and outcomes even though it cannot prevent the condition. Annual physical examinations for all dogs and more frequent examinations for predisposed breeds allow early murmur detection. Dogs diagnosed with murmurs should undergo echocardiography to characterize the valve disease and establish baseline measurements. Regular monitoring tracks progression and identifies optimal timing for treatment initiation. Dental care, parasite prevention, and management of concurrent health conditions all support overall health in dogs with valve disease.

Early intervention when valve disease is diagnosed maximizes the benefits of available therapies. Dogs with significant cardiac enlargement but without symptoms may benefit from starting pimobendan, which has been shown to delay heart failure onset. Once symptoms develop, prompt initiation of comprehensive medical therapy improves quality of life and survival. Identifying surgical candidates early allows for intervention before severe heart failure develops, improving surgical outcomes. Regular follow-up ensures treatment adjustments are made promptly as disease progresses. Owner education about symptom monitoring enables early detection of decompensation between veterinary visits.

Daily management for dogs living with valve disease requires establishing consistent medication routines and monitoring practices. Most dogs with symptomatic valve disease require multiple medications given one to three times daily, and consistent timing ensures stable drug levels for optimal effect. Owners should develop systems for tracking medication administration, such as pill organizers or smartphone apps, to prevent missed or double doses. Prescribed diets should be fed consistently without unauthorized treats or table food that may contain excessive sodium. Activity guidelines vary among patients but generally encourage regular moderate exercise tailored to the individual dog's tolerance, with rest allowed when needed.

Home environment modifications support dogs with valve disease and heart failure. Climate control through air conditioning during hot weather prevents heat stress that increases cardiac workload. Reducing the need to climb stairs through ramps or carrying the dog minimizes exertion. Elevated food and water bowls may be more comfortable for dogs with respiratory symptoms. Non-slip surfaces throughout the home prevent falls in dogs with any weakness. A comfortable bed in a quiet, cool location promotes restful sleep, particularly important since dogs with valve disease often have disrupted sleep due to coughing or positional breathing difficulty.

Maintaining quality of life for dogs with valve disease balances necessary restrictions against opportunities for enjoyment. While strenuous activity may need to be limited, gentle walks, calm play sessions, and social interaction contribute to mental and emotional wellbeing. Dogs should not be completely restricted from enjoyable activities unless specifically advised by the veterinarian. Mental stimulation through puzzle toys, gentle training, and engagement with family members keeps dogs mentally active. Adjusting expectations while maximizing quality experiences helps both dogs and owners adapt to living with chronic heart disease.

Monitoring and ongoing care for dogs with valve disease centers on tracking respiratory status and overall condition. Resting respiratory rate monitoring is one of the most valuable tools for early detection of decompensation. Owners should learn to count breaths while the dog rests comfortably, with rates consistently above 30 to 40 breaths per minute warranting veterinary contact. Changes in energy level, appetite, coughing frequency, or breathing comfort should be noted and reported. Regular veterinary appointments, typically every three to six months for stable patients, allow professional assessment and medication adjustment.

Caregiver support addresses the emotional and practical challenges of managing a dog with progressive heart disease. The daily commitment to medication administration, dietary restrictions, and monitoring can be demanding. Financial costs for medications, regular veterinary care, and potential emergencies accumulate over time. Emotional stress from watching a beloved pet decline and from the uncertainty of prognosis affects many owners. Support from family, friends, and online communities helps owners cope. Open communication with the veterinary team about realistic expectations, quality of life assessment, and end-of-life planning prepares owners for difficult decisions while maximizing the quality of remaining time together.

Small breed dogs face dramatically elevated risk for degenerative valve disease, with prevalence far exceeding that in large breeds. Cavalier King Charles Spaniels have the highest documented prevalence, with virtually all dogs developing some degree of valve disease and many showing changes before middle age. Dachshunds, Miniature and Toy Poodles, Chihuahuas, Maltese, Yorkshire Terriers, Miniature Schnauzers, and Cocker Spaniels all show increased prevalence compared to the general dog population. King Charles Spaniels, Papillons, and Pomeranians are similarly predisposed. The strong breed associations underscore the genetic basis of degenerative valve disease and guide recommendations for cardiac screening in these breeds.

Moderate-risk breeds and other populations affected by valve disease include some larger breeds with specific congenital valve defects. Golden Retrievers, German Shepherds, Newfoundlands, and Rottweilers have increased prevalence of subaortic stenosis, a congenital narrowing below the aortic valve. Bull Terriers are prone to mitral valve dysplasia. English Bulldogs and Labrador Retrievers show increased rates of pulmonic stenosis. Large breed dogs can develop degenerative valve disease, though less commonly and typically at older ages than small breeds. Mixed breed dogs are not immune and may develop valve disease based on their genetic background.

Screening recommendations for at-risk breeds emphasize regular cardiac evaluation to detect valve disease early. All dogs should have cardiac auscultation at annual wellness visits. Small breed dogs, particularly those from predisposed breeds, benefit from echocardiographic screening to detect early changes before murmurs become prominent. Breeding dogs from predisposed breeds should undergo cardiac certification before breeding, with echocardiography performed by a board-certified cardiologist. Breed clubs for Cavalier King Charles Spaniels and other highly affected breeds have developed specific screening protocols that breeders should follow to reduce disease transmission to future generations.

Commonly co-occurring conditions with valve disease reflect the cardiovascular consequences of chronic volume overload and the aging process in predisposed dogs. Congestive heart failure is the primary complication of progressive valve disease, developing when cardiac compensation fails. Pulmonary hypertension, elevated pressure in the lung blood vessels, frequently accompanies significant mitral valve disease and worsens prognosis. Atrial fibrillation, an irregular heart rhythm originating in the enlarged atria, commonly develops in advanced valve disease and complicates management. Concurrent tracheal collapse is common in small breed dogs and contributes to coughing that may be difficult to distinguish from cardiac cough. Dental disease is prevalent in small breeds and requires careful management to prevent endocarditis on diseased valves.

Conditions with symptoms similar to valve disease require differentiation for accurate diagnosis and treatment. Tracheal collapse causes coughing in small breeds but is not cardiac in origin. Chronic bronchitis produces cough and respiratory symptoms unrelated to heart disease. Primary respiratory diseases including pneumonia and pulmonary fibrosis may cause breathing difficulty similar to heart failure. Dilated cardiomyopathy, more common in large breeds, causes heart failure through muscle weakness rather than valve dysfunction. Heartworm disease can cause heart failure and must be ruled out in endemic areas. Non-cardiac causes of exercise intolerance, such as orthopedic disease or anemia, may be confused with cardiac limitation.

Potential complications of valve disease include life-threatening acute events and progressive deterioration. Left atrial tear, where the enlarged atrium ruptures, causes sudden cardiac tamponade and requires emergency intervention. Ruptured chordae tendineae, the cords anchoring valve leaflets, causes acute worsening of regurgitation. Severe pulmonary edema can develop rapidly during acute decompensation. Arrhythmias may cause syncope or sudden death. Cardiogenic cachexia, muscle wasting despite adequate nutrition, affects dogs with advanced disease. Thromboembolic events may occur with severely enlarged atria. Recognizing these complications and having plans for emergency care helps owners respond appropriately when crises develop.